| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An epidemiologic survey of cardiovascular disease in women taking oral contraceptives
|
Thorogood, Margaret
|
|
1990
|
163 |
1P2 |
p. 274-281
8 p.
|
artikel
|
| 2 |
Cardiovascular death among women under 40 years of age using low-estrogen oral contraceptives and intrauterine devices in Finland from 1975 to 1984
|
Hirvonen, Erkki
|
|
1990
|
163 |
1P2 |
p. 281-284
4 p.
|
artikel
|
| 3 |
Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease
|
Gaspard, Ulysse J.
|
|
1990
|
163 |
1P2 |
p. 334-343
10 p.
|
artikel
|
| 4 |
Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: Relation to the development of cardiovascular disease
|
Kelleher, Cecily C.
|
|
1990
|
163 |
1P2 |
p. 392-395
4 p.
|
artikel
|
| 5 |
Comparative studies of 30 μg ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets
|
Daly, Leisha
|
|
1990
|
163 |
1P2 |
p. 430-437
8 p.
|
artikel
|
| 6 |
Disorders of the hemostatic system and the risk of the development of thrombotic and cardiovascular diseases: Limitations of laboratory diagnosis
|
Kluft, Cornelis
|
|
1990
|
163 |
1P2 |
p. 305-312
8 p.
|
artikel
|
| 7 |
Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: A one-year randomized, prospective, comparative trial
|
Jandrain, Bernard J.
|
|
1990
|
163 |
1P2 |
p. 378-381
4 p.
|
artikel
|
| 8 |
Effects of long-term gestodene-containing oral contraceptive administration on hemostasis
|
Abbate, Rosanna
|
|
1990
|
163 |
1P2 |
p. 424-429
6 p.
|
artikel
|
| 9 |
Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid
|
Jespersen, Jørgen
|
|
1990
|
163 |
1P2 |
p. 396-403
8 p.
|
artikel
|
| 10 |
Effects of oral contraceptives on carbohydrate and lipid metabolisms in a healthy population: The Telecom Study
|
Simon, Dominique
|
|
1990
|
163 |
1P2 |
p. 382-387
6 p.
|
artikel
|
| 11 |
Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyI estradiol on lipid metabolism in comparison with two levonorgestrel preparations
|
Kloosterboer, Helenius J.
|
|
1990
|
163 |
1P2 |
p. 370-373
4 p.
|
artikel
|
| 12 |
Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogen
|
Gram, Jørgen
|
|
1990
|
163 |
1P2 |
p. 438-442
5 p.
|
artikel
|
| 13 |
Estrogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism
|
Gevers Leuven, Jan A.
|
|
1990
|
163 |
1P2 |
p. 358-362
5 p.
|
artikel
|
| 14 |
Hemostasis profile in women taking low-dose oral contraceptives
|
David, J.L.
|
|
1990
|
163 |
1P2 |
p. 420-423
4 p.
|
artikel
|
| 15 |
Impairment of glucose tolerance: Mechanism of action and impact on the cardiovascular system
|
Beck-Nielsen, Henning
|
|
1990
|
163 |
1P2 |
p. 292-295
4 p.
|
artikel
|
| 16 |
Influence of oral contraceptives on coagulation tests in native blood and plasma
|
Kunz, Friedebert
|
|
1990
|
163 |
1P2 |
p. 417-420
4 p.
|
artikel
|
| 17 |
Interrelations between carbohydrates, lipids, and the hemostatic system in relation to the risk of thrombotic and cardiovascular disease
|
Juhan-Vague, Irene
|
|
1990
|
163 |
1P2 |
p. 313-315
3 p.
|
artikel
|
| 18 |
Introductory remarks
|
Jespersen, Jorgen
|
|
1990
|
163 |
1P2 |
p. 273-
1 p.
|
artikel
|
| 19 |
Low-dose oral contraceptives and carbohydrate metabolism
|
Godsland, Ian F.
|
|
1990
|
163 |
1P2 |
p. 348-353
6 p.
|
artikel
|
| 20 |
Mechanism of action of oral contraceptives on carbohydrate metabolism at the cellular level
|
Skouby, Sven O.
|
|
1990
|
163 |
1P2 |
p. 343-348
6 p.
|
artikel
|
| 21 |
Metabolic changes during the normal menstrual cycle: A longitudinal study
|
Lebech, Anne-Mette
|
|
1990
|
163 |
1P2 |
p. 414-416
3 p.
|
artikel
|
| 22 |
Metabolic changes during treatment with two different progestogens
|
Refn, Hanne
|
|
1990
|
163 |
1P2 |
p. 374-377
4 p.
|
artikel
|
| 23 |
Oral contraceptives in risk groups: Exclusion or monitoring?
|
Guillebaud, John
|
|
1990
|
163 |
1P2 |
p. 443-446
4 p.
|
artikel
|
| 24 |
Past use of oral contraceptives and cardiovascular disease: A meta-analysis in the context of the Nurses’ Health Study
|
Stampfer, Meir J.
|
|
1990
|
163 |
1P2 |
p. 285-291
7 p.
|
artikel
|
| 25 |
Pharmacokinetics of gestagens: Some problems
|
Fotherby, K.
|
|
1990
|
163 |
1P2 |
p. 323-328
6 p.
|
artikel
|
| 26 |
Protein binding of active ingredients and comparison of serum ethinyl estradiol sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene/ ethinyl estradiol (Femovan) or a combination of desogestrel/ ethinyl estradiol (Marvelon) and single-dose ethinyl estradiol bioequivalence from both oral contraceptives
|
Hümpel, Michael
|
|
1990
|
163 |
1P2 |
p. 329-333
5 p.
|
artikel
|
| 27 |
Role of plasma lipoproteins in the pathogenesis of atherosclerotic disease, with special reference to sex hormone effects
|
Tikkanen, Matti J.
|
|
1990
|
163 |
1P2 |
p. 296-304
9 p.
|
artikel
|
| 28 |
Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications
|
Goldzieher, Joseph W.
|
|
1990
|
163 |
1P2 |
p. 318-322
5 p.
|
artikel
|
| 29 |
Some aspects of the relationship between oral contraceptives, lipid abnormalities, and cardiovascular disease
|
Samsioe, Göran
|
|
1990
|
163 |
1P2 |
p. 354-358
5 p.
|
artikel
|
| 30 |
Studies on the mechanism of action of oral contraceptives with regard to fibrinolytic variables
|
Kooistra, Teake
|
|
1990
|
163 |
1P2 |
p. 404-413
10 p.
|
artikel
|
| 31 |
The clinical relevance of oral contraceptive pill-induced plasma lipid changes: Facts and fiction
|
Hoppe, Gundolf
|
|
1990
|
163 |
1P2 |
p. 388-391
4 p.
|
artikel
|
| 32 |
Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives
|
Kuhl, Herbert
|
|
1990
|
163 |
1P2 |
p. 363-369
7 p.
|
artikel
|
| 33 |
Why do we need pharmacokinetic studies?
|
Hvidberg, Eigill F.
|
|
1990
|
163 |
1P2 |
p. 316-318
3 p.
|
artikel
|
Tijdschrift beschrijving